Citigroup’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-500
Closed -$3K 6765
2022
Q1
$3K Buy
+500
New +$3.54K ﹤0.01% 6003
2016
Q1
Sell
-21
Closed 7825
2015
Q4
$0 Buy
+21
New +$229 ﹤0.01% 7919
2015
Q3
Sell
-56
Closed -$1K 7775
2015
Q2
$1K Buy
+56
New +$872 ﹤0.01% 7355

Other funds holding PMD

Citigroup's PMD Position: Q2 2022 in Review

Citigroup sold out of Psychemedics Corporation (PMD) in Q2 2022, closing a stake of 500 shares — an estimated $3K sold.

Citigroup first reported a position in PMD in Q2 2015 and held it in 3 quarters. The position peaked at $3K in Q1 2022. 21 funds tracked by Wall St. Rank hold PMD as of Q2 2022.

  • Citigroup reported no remaining Psychemedics Corporation position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 500 Psychemedics Corporation shares in Q2 2022, an estimated $3K.
  • Citigroup first reported a position in Psychemedics Corporation in Q2 2015 and held it in 3 quarters.
  • Citigroup's Psychemedics Corporation position peaked at $3K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.